Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 56 filings·Updated 24 Aug 2026
Showing 10 of 56 filings.
24 Aug 20262 filings
Company UpdateAllotment of Securities

Genesys International Rights Issue Allotment of Equity Shares Approved

Key Update

  • Rights issue of 2,50,74,226 equity shares at ₹50 per share (₹5 face, ₹45 premium) approved.
  • Board approved the rights issue on 24 August 2026.
  • Basis of allotment finalized with Registrar Bigshare Services Private Limited and approved by BSE.
  • Post-rights paid-up capital: 6,68,64,603 shares; ₹33,34,23,015.
  • Pre-rights paid-up capital: 4,17,90,377 shares; ₹20,89,51,885.
  • Shares rank pari passu with existing equity.
Filed 20:34View Source
Company UpdateAllotment of Equity Shares

Genesys International Corporation Limited informed the Exchange regarding Allotment of Equity Shares pursuant to Right Issue

Filed 20:29View Source
17 Aug 20261 filing
Company UpdateGeneral

Genesys International appoints Nikhil Alulkar as Chief Executive Officer

CEO appointment

  • Appoints Nikhil Alulkar as Chief Executive Officer; formerly Head - India Business and Sr. VP at Tech Mahindra.
  • CEO will lead operations, scaling AI-native mapping and Digital Twin platforms, and expand enterprise and government markets.
Filed 09:00View Source
16 Aug 20262 filings
Company UpdateCopy of Newspaper Publication

Please find enclosed a copy of Newspaper Publication of Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 as published in the newspaper - The Free Press Journal (English) and Navshakti (Marathi)

Filed 20:17View Source
Company UpdateNewspaper Publication

Please find enclosed a copy of Newspaper Publication of Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 as published in the ....

Filed 20:07View Source
14 Aug 20262 filings
Company UpdateMonitoring Agency Report

Monitoring Agency flags deviation in Genesys QIP proceeds and timeline extension

Issue overview

  • Type: QIP of equity shares.
  • Total size and net proceeds: revision/extension observed.
  • Main uses: data centre, tech platform, map content, sensors, IT infra, and GCP.

Utilisation and status

  • Utilisation not fully per offer document; timeline extended.
  • Funds moved between MA and current account, causing comingling.
  • Unutilised funds parked in fixed deposits and monitoring account.
  • Manpower cost reimbursements within tech platform object; other objects unchanged.
  • Management approved extended deployment timeline.

Governance and compliance

  • Approvals: CFO approved timeline revision; no shareholder approvals noted.
  • Regulatory actions: exchanges fined for SEBI LODR non-compliance.
  • Market concerns: share price decline; promoter pledge increased; independent director vacancy.

GCP

  • GCP status: no utilisation in the period; allocation categories defined.
  • Board-approved GCP allocations include salaries, taxes, admin costs.

Unutilised proceeds deployment

  • Unutilised proceeds invested in fixed deposits and monitoring balance.
  • No accrued interest parked in fixed deposits as of reporting date.
Filed 20:27View Source
Board MeetingOutcome of Board Meeting

Genesys International approves Q1 FY2026 unaudited results and appoints CEO with CTO redesignation and new CTO

Financial results approved

  • Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved.
  • Limited Review Report on results enclosed.

Management appointments and role changes

  • Nikhil Alulkar appointed CEO and KMP, effective Aug 14, 2026.
  • Aniruddha Roy redesignated from CTO to Chief Innovation Officer, effective Aug 14, 2026.
  • Dhiman Basu Ray appointed Chief Technology Officer, effective Aug 14, 2026.

Regulatory disclosures and annexures

  • Annexures A and B filed detailing results and KMP changes under SEBI LODR.
Filed 20:05View Source
11 Aug 20262 filings
Company UpdateCopy of Newspaper Publication

Genesys International Corporation Limited has informed the Exchange about Copy of Newspaper Publication of Issue Programme for Rights Issue

Filed 18:01View Source
Company UpdateNewspaper Publication

Newspaper Publication of Issue Programme for Rights Issue

Filed 17:58View Source
10 Aug 20261 filing
Board Meeting

Genesys Board to consider unaudited standalone and consolidated results for Q1 ended June 30, 2026

Meeting Details

  • Date: August 14, 2026; Location: registered office; Time not disclosed.

Key Agenda Items

  • Consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2026.

Other Notes

  • No trading window closure period specified.
Filed 18:19View Source
Showing 10 of 56 filings